Gagnon, P., Cheung, C.-W., Lepin, E.J., Wu, A.M., Sherman, M.A., Raubitschek, A., and Yazaki, P.J. Minibodies and Multimodal Chromatography Methods. (2010) BioProcess International, 8(2):26–35.
Leyton, J.V., Olafsen, T., Sherman, M.A., Bauer, K., Aghajanian, P., Reiter, R.E., and Wu, A.M. (2009) Engineered humanized diabodies for rapid microPET imaging of prostate stem cell antigen-expressing tumors. Protein Engineering, Design and Selection 22(3): 209–216.
Yazaki, P.J., Kassa T., Cheung, C-W., Crow, D.M. Sherman, M.A., Bading, J.R., Anderson, A-L.J., Colcher, D., and Raubitschek, A. (2008) Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein. Nuclear Medicine and Biology 35:151-158.
Olafsen, T., Gu, Z., Sherman, M.A., Leyton, J.V., Witkosky, M.E., Shively, J.E., Raubitschek, A.A., Morrison, S.L., Wu, A.M., Reiter, R.E. (2007) Targeting, imaging, and therapy using a humanized anti-prostate stem cell antigen (PSCA) antibody. Journal of Immunotherapy 30(4):396-405.
Yazaki, P.J., Sherman, M.A., Shively, J.E., Ikle, D. Williams, L.E., Wong, J.Y.C., Colcher, D., Wu, A.W., Raubitschek, A.A. (2004) Humanization of the Anti-CEA T84.66 Antibody Based on Crystal Structure Data. Protein Engineering, Design, and Selection 17(5):481-489.
Olafsen, T., Cheung, C-W., Yazaki, P.J., Li, L., Sundaresan, G., Gambhir, S.S., Sherman, M.A., Williams, L.E., Shively, J.E., Raubitschek, A.A., and Wu, A.M. (2004) Covalent Disulfide-Linked Anti-CEA Diabody Allows Site-Specific Conjugation and Radiolabeling for Tumor Targeting Applications. Protein Engineering Design and Selection 17(1):21-27.
Wu, A.M., Tan, G.J., Sherman, M.A., Clarke, P., Olafsen, T., Forman, S.J., and Raubitschek, A.A. (2001) Multimerization of a Chimeric Anti-CD20 Single Chain Fv-Fc Fusion Protein is Mediated through Variable Domain Exchange. Prot. Eng. 14(12):1025-1033.
Wu, A.M., Williams, L.E., Zieran, L., Padma, A. Sherman, M. Bebb, G.G., Odom-Maryon, T. Wong, J.Y.C., Shively, J.E., and Raubitschek, A. (1999) Anti-Carcinoembryonic Antigen (CEA) Diabody for Rapid Tumor Targeting and Imaging. Tumor Targeting 4:47-58.
Neumaier, M., Galda, F.-J., Piper, D., Sherman, M.A., and Shively, J.E. (1997) Immunological and Molecular Characterization of an Idiotypic Cascade Specific for the Human Carcinoembryonic Antigen (CEA). In: Idiotypes In Medicine - Infections, Autoimmunity and Cancer, (Y. Shoenfeld, R.C. Kennedy, S. Ferrone, eds.) Elsevier, New York. pp. 461-475.
Wu, A.M., Williams, L.E., Bebb, G.G., Sherman, M., Wong, J.Y.C., Shively, J.E., Raubitschek, A.A. (1997) “Selection of engineered antibody fragments for targeting and imaging applications.” In: Antibody Engineering: New Technologies, Applications & Commercialization, Volume 2, (W. Hori, ed.). IBC BioMedical Library, Southborough, MA, pp.163-183.
Wu, A.M., Hu, S.-Z., Chen, W., Zieran, L., Shively, L., Sherman, M., Shively, J.E., Williams, L.E., Wong, J.Y.C., Raubitschek, A.A. (1996) “Rapid tumor targeting and imaging by engineered fragments.” In: Antibody Engineering: New Technologies, Applications & Commercialization (C. Thibeault, Ed.). IBC BioMedical Library, Southborough, MA, pp. 126-144.
Hu, S.-Z., Shively, L., Raubitschek, A.A., Sherman, M., Williams, L.E., Wong, J.Y.C., Shively, J.E., and Wu, A.M. (1996) Minibody: A Novel Engineered Anti-Carcinoembryonic Antigen Antibody Fragment (Single-Chain Fv-CH3) Which Exhibits Rapid, High Llevel Targeting of Xenografts. Cancer Res. 56:3055-3061.
Bolger, M.B., and Sherman, M.A. (1991) “Computer Modeling of the Combining Site Structure of Anti-Hapten Monoclonal Antibodies.” Methods in Enzymology 203:21-45.
Kussie, P.H., Sherman, M.A., Marchetti, D., and Linthicum, D.S. (1989) “Molecular Analysis of Monoclonal Idiotypes and Anti-Idiotypes.” Methods in Enzymology 178:91-107.
Bolger, M.B., Sherman, M.A., and Linthicum, D.S. (1988) “Molecular Characterization of Anti-Neuroleptic Idiotypes and Anti-Idiotypes.” Chapter 9 in Anti-idiotypes, Receptors, and Molecular Mimicry, (Eds. D.S. Linthicum and N.R. Farid), Springer-Verlag, New York.
Sherman, M.A., and Bolger, M.B. (1988) Haloperidol Binding to Monoclonal Antibodies: Predictions of 3D Combining Site Structure via Computer Modeling. J. Biol. Chem. 263:4064-4074.
Sherman, M.A., Deans, R.J., and Bolger, M.B. (1988) Haloperidol Binding to Monoclonal Antibodies: Hypervariable Region Amino Acid Sequence Determination. J. Biol. Chem. 263:4059-4063.
Sherman, M.A., Linthicum, D.S., and Bolger, M.B. (1986) Haloperidol Binding to Monoclonal Antibodies: Conformational Analysis and Relationships to D-2 Receptor Binding. Mol. Pharm. 29: 589-598.
US Patents
Yazaki, P.J., Sherman, M.A., Shively, J.E., Raubitschek, A.A., and Wu, A.M. “Humanized Anti-CEA T84.66 antibody and uses thereof”: US Patent 7,273,608 (granted September 25, 2007).
US Patent Applications
Sherman, M.A., Wu, A. and Reiter, R. “Humanized anti-prostate stem cell antigen monoclonal antibody.” Published US Patent Application 20060269557 (November 30, 2006).
Link to PubMed search results for publications by this author.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 04/10
